WuXi AppTec

WuXi AppTec is one of the world’s leading Contract Research, Development, and Manufacturing Organizations (CRDMOs), providing integrated pharmaceutical and biotechnology services from early-stage discovery through commercial manufacturing. Founded in 2000 and headquartered in Shanghai, China, the company serves thousands of customers across more than 30 countries, including global pharmaceutical companies, emerging biotechnology firms, and academic institutions.

WuXi AppTec offers a comprehensive range of services including medicinal chemistry, biology, preclinical testing, laboratory analysis, process development, API manufacturing, biologics development, cell and gene therapy support, clinical trial manufacturing, regulatory consulting, and commercial production. Its integrated research and manufacturing platform enables customers to accelerate drug development while reducing cost and time to market.

The company operates a worldwide network of research centers and GMP manufacturing facilities across China, the United States, Europe, and Singapore. WuXi continuously invests in automation, artificial intelligence, digital laboratories, and advanced manufacturing technologies to enhance efficiency and scientific innovation. Its facilities comply with international quality standards established by regulatory authorities such as the US FDA, EMA, NMPA, PMDA, and other global agencies.

Through scientific excellence, large-scale infrastructure, and comprehensive service offerings, WuXi AppTec has become one of the most influential pharmaceutical outsourcing partners in the global life sciences industry.